Chemed (NYSE: CHE) discloses Q3 2025 results via earnings release
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Chemed Corporation filed a current report stating that on October 28, 2025 it issued a press release announcing its financial results for the quarter ended September 30, 2025. The company notes that this press release is furnished as Exhibit 99 to the report, making the detailed quarterly results available through that exhibit.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
FAQ
What did Chemed (CHE) disclose in this Form 8-K?
Chemed reported that it issued a press release announcing its financial results for the quarter ended September 30, 2025, and furnished that release as Exhibit 99.
Which period do the reported Chemed (CHE) results cover?
The financial results discussed in the press release relate to Chemed’s quarter ended September 30, 2025.
When did Chemed issue the press release about its quarterly results?
Chemed issued the press release on October 28, 2025, the same date referenced as the event date in the report.
Where can investors find the detailed Chemed Q3 2025 results?
The detailed quarterly results are contained in Chemed’s press release, which is furnished as Exhibit 99 to this report.
Which item of the 8-K does Chemed use to report these results?
Chemed reports the quarterly financial results under Item 2.02 Results of Operations and Financial Condition.
Who signed this Chemed (CHE) Form 8-K?
The report was signed on behalf of Chemed Corporation by Michael D. Witzeman, Executive Vice President and Chief Financial Officer.